Marshall Wace, LLP Standard Biotools Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Standard Biotools Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 81,617 shares of LAB stock, worth $151,807. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,617
Previous 23,472
247.72%
Holding current value
$151,807
Previous $51,000
333.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding LAB
# of Institutions
146Shares Held
265MCall Options Held
356KPut Options Held
400-
Casdin Capital, LLC New York, NY61.9MShares$115 Million13.55% of portfolio
-
Viking Global Investors LP58.7MShares$109 Million0.61% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny14.4MShares$26.7 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13MShares$24.3 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$24.2 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $146M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...